¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõÁö·ç¼ºÇǺο° Ä¡·á °¡±îÀÌ¿¡

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#ÀÎõÁö·ç¼ºÇǺο°, #ÀÎõÁö·ç¼ºÇǺο°Ä¡·á, #ÇÑÆ÷Áø, #ÀÎõÇÑÆ÷Áø, #Áö·ç¼ºÇǺο°Ä¡·á, #ÇÑÆ÷ÁøÄ¡·á, #ÀÎõÇÑÆ÷Áø, #ºÎõÁö·ç¼ºÇǺο° ÀÎõÁö·ç¼ºÇǺο°,,ÀÎõÁö·ç¼ºÇǺο°Ä¡·á,,ÇÑÆ÷Áø,,ÀÎõÇÑÆ÷Áø,,Áö·ç¼ºÇǺο°Ä¡·á,,ÇÑÆ÷ÁøÄ¡·á,,ÀÎõÇÑÆ÷Áø,,ºÎõÁö·ç¼ºÇǺο° ¾È³çÇϼ¼¿ä. ÀÎõÁö·ç¼ºÇǺο° ºÎõ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ÀÎõÁö·ç¼ºÇǺο° ºÎõ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ÀÎõÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´ÂÇÑÆ÷Áø, ÆíÆòż±, µî¾ÆÅäÇÇ, ¾ÆÅäÇÇÇѾà, ż±, ¾ÆÅäÇÇÇǺÎ, °Ç¼±ÇÑÀÇ¿ø, µÎµå·¯±âÇÑÀÇ¿ø, ½É»ó¼º°Ç¼±, ¼Õ°¡¶ô¼öÆ÷, Áö·ç¼ºÇǺο°, ½ÀÁø°¡·Á¿ò, ÇÑ·©µÎµå·¯±â, Áö·çÇǺο°, Á¢Ã˼ºÇǺο°, ¾àÁø, ¿Â¸öµÎµå·¯±â, ¼Õ°¡¶ô°Ç¼±, ¼ÕÅé»ç¸¶±Í, Àü½Å½ÀÁø, ¾Æ±â¾ó±¼È«Á¶, °Ç¼ºµÎÇÇ, ÇǺλ縶±Í, ¾È¸éÈ«Á¶, ¾ÆÅäÇÇ°ü¸®µî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó ICT, ü¿­Áø´Ü±â, º¹Àâ±³Á¤Ãß³ª, ¹Ì¼¼¾àÃÊÀڱؿä¹ý, ¹°¸®Ä¡·á, ÇÁ·Ñ·ÎÅ׶óÇÇ, EST, ¾à¹°¿ä¹ý, ÀÌ¿ÂÀüÀÚÀڱؿä¹ý, µµÀο¿ä¹ý, Ç¥Àç¿­Ä¡·á, °üÀýºÀ¾àħ¿ä¹ý, ½ÃÇÁ°Ö, ºÀ¾àħ, ¸ÆÆÄ°Ë»ç, Ç÷¸Æ¾îÇ÷°Ë»ç, Àú¿¡³ÊÁö·¹ÀÌÀú, ¿Â¿­Ä¡·á, ºñ¸¸Ä§, Àåħ, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç ¿ï»ê Áß±¸ ¼º¾Èµ¿, ºÎ»ê ºÏ±¸ ±¸Æ÷3µ¿, °æ±â ¿À»ê½Ã °íÇöµ¿, ÀÎõ Áß±¸ ¼ÛÇе¿1°¡, ÀüºÏ ÀüÁֽà ´öÁø±¸ ÁøºÏµ¿, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¾È¾ç8µ¿, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¾È¾ç1µ¿, ºÎ»ê ¿¬Á¦±¸ °ÅÁ¦3µ¿, °æºÏ ¾Èµ¿½Ã ³ëÇϵ¿, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¼®¼ö3µ¿, ÀüºÏ Áø¾È±º ¿ë´ã¸é, ÀÎõ ³²µ¿±¸ ¸¸¼ö5µ¿, Ãæ³² ³í»ê½Ã °¡¾ß°î¸é, °­¿ø ȫõ±º ¼­¼®¸é, ÀüºÏ Áø¾È±º ¾Èõ¸é, ºÎ»ê °­¼­±¸ õ¼ºµ¿, °æºÏ °æ»ê½Ã ¿ÍÃ̸é, °æ±â µ¿µÎõ½Ã µ¿µÎõµ¿, °æºÏ Æ÷Ç׽à ºÏ±¸ âÆ÷µ¿, °æ±â ºÎõ½Ã ¿ÀÁ¤±¸ °í°­µ¿, ÃæºÏ Á¦Ãµ½Ã Á¦Ãµ¿ìü±¹»ç¼­ÇÔ, °æºÏ ¿µ´ö±º ¿µ´öÀ¾, ºÎ»ê ºÎ»êÁø±¸ ´ç°¨1µ¿, Àü³² À强±º ¼­»ï¸é, ÀüºÏ ÀüÁֽà ´öÁø±¸ ÀÎÈĵ¿2°¡, °æºÏ °æ»ê½Ã ³²Ãµ¸é, ÀüºÏ ±èÁ¦½Ã ±èÁ¦¿ìü±¹»ç¼­ÇÔ, ÀÎõ °è¾ç±¸ ¿ëÁ¾µ¿, °æºÏ ¿µÃµ½Ã Àۻ굿, ÀÎõ ¼­±¸ °¡ÁÂ3µ¿, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ÀÎõÁö·ç¼ºÇǺο°Ä¡·á ãÀ¸½Ã´Â ¸¸¼öµ¿, ºÎõ, Á־ȿª, ÀÎõÁÖ¾È, Áß±¸, ³²µ¿±¸, µµÈ­µ¿, ÀÎõ, ÀÎõ¼­±¸, ¿î¼­µ¿, ¿µÈïµµ, ¸Å¼Û¸é, û¶ó, µ¿±¸, ¼Û¿ùµ¿, ¹è°ð, ¿Á·Ãµ¿, ¼®³²µ¿, ¼Û¸²µ¿, Áßµ¿, ºÀ´ãÀ¾, ÀÛÀüµ¿, ûÇе¿, Á־ȵ¿, ÆÈź¸é, ¿¬Èñµ¿, ±¸¿ùµ¿, ¸¶µµ¸é, ¼±Çе¿, ÀÎõ³íÇö, µ¿Ãᵿ, ¿ëÀ¯µµ, µ¿ÀÎõ, ºñºÀ¸é, ÇÐÀ͵¿ µî ÀÎõ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿øÀÎõÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Sarre ME, Martin L, Moote W, et al. Are baths desirable in atopic dermatitis? J Eur Acad Dermatol Venereol 2015; 29:1265. 2. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol 2014; 71:116. 3. Rikkers SM, Holland GN, Drayton GE, et al. Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol 2003; 135:297. 4. Bonnel RA, La Grenade L, Karwoski CB, Beitz JG. Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience. J Am Acad Dermatol 2003; 48:294. 5. van Zuuren EJ, Fedorowicz Z, Christensen R, et al. Emollients and moisturisers for eczema. Cochrane Database Syst Rev 2017; 2:CD012119. 6. www.accessdata.fda.gov/drugsatfda_docs/label/2017/761055lbl.pdf (Accessed on April 04, 2017). 7. Margolis DJ, Hoffstad O, Bilker W. Lack of association between exposure to topical calcineurin inhibitors and skin cancer in adults. Dermatology 2007; 214:289. 8. Schram ME, Spuls PI, Leeflang MM, et al. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy 2012; 67:99. 9. Thaçi D, Simpson EL, Beck LA, et al. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet 2016; 387:40.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõÁö·ç¼ºÇǺο° Ä¡·á °¡±îÀÌ¿¡""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõºÒÀÓÇѾà ÇÑÀÇ¿ø ¼­µÎ¸£¼¼¿ä
´ÙÀ½±Û ÀÎõÃà³óÁõ Ä¡·á °í¹ÎÇØ°á
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
792 °­µ¿±¸ ÂüÇÑÀÇ¿ø »õÇØ 1¿ù ÇÒÀÎ À̺¥Æ® ¾È³» 0 944 2021-01-04
791 ½º¸¶Æ®ÇÑÀÇ¿ø 1¿ù À̺¥Æ® 0 905 2021-01-04
790 ¼­¿ï ºÎºÎ ÇÑÀÇ¿ø 1¿ù ¼ºÀå À̺¥Æ® ¾È³»µå·Á¿ä 0 1,233 2021-01-04
789 û´çÁÖÇÑÀÇ¿ø 1¿ù À̺¥Æ®¾È³» 0 1,776 2021-01-04
788 ½ÅÃÌÁ¤°Ü¿îÇÑÀÇ¿ø 1¿ùÀ̺¥Æ® 0 1,261 2020-12-31
787 â¿øÇǺο캸ÇÑÀÇ¿ø! 2021³âÀ» »õ·Ó°Ô ¸ÂÀÌÇÏ¼Ò 0 1,289 2020-12-31
786 2021³â »õÇظÂÀÌ ´Ù³ªÇÑÀÇ¿ø ÇÒÀÎÀ̺¥Æ® 0 3,618 2020-12-31
785 ±Ô¸²ÇÑÀÇ¿ø õ¾ÈÁ¡ 2021³â ù À̺¥Æ® ¹Ì¸® ¾Ë·Áµå¸³´Ï´Ù 0 1,599 2020-12-31
784 [¹Ý¿ù´çÇÑÀÇ¿ø] ¶óÀ²ÇÑÀÇ¿ø ½Å³â¸ÂÀÌ 1¿ù À̺¥Æ® 0 890 2020-12-31
783 [¸®»ùÇÑÀÇ¿ø ÀÏ»êÁ¡]2021³â 1¿ùÀ̺¥Æ®¾È³» 0 856 2020-12-29
782 ÁøÁֽà ´ÙÀ̾îÆ® º½ÇÑÀÇ¿ø ¼öÇè»ý ÇÒÀÎ 0 1,984 2020-12-23
781 ÁöÅ°¹ÌÇÑÀÇ¿ø ¼öÇè»ý ÇÒÀÎ À̺¥Æ®! ¼±Âø¼ø 30¸í±îÁö ÇÒÀÎÇصå·Á¿ä!! 0 1,032 2020-12-23
780 ÀϸÆÇÑÀÇ¿ø ºÎ»êÁ¡ 12¿ù À̺¥Æ® ¾È³» 1 1,485 2020-12-17
779 ¼öÇÑÀÇ¿ø 12¿ù ¼öÇè»ýÇÒÀÎÀ̺¥Æ® 0 1,403 2020-12-08
778 ´ë±¸´Þ¼­±¸ÇÑÀÇ¿ø Æ°Æ°ºÎºÎÇÑÀÇ¿ø 0 2,126 2020-12-08
777 °­µ¿±¸ ÂüÇÑÀÇ¿ø 12¿ù ÇÒÀÎ ÇÁ·Î¸ð¼Ç 0 1,012 2020-12-08
776 ¼­¸é´ÙÀ̾îÆ®ÇÑÀÇ¿ø°Ë»ö, °íµç¸öÇÑÀÇ¿øÀÌ Áø¸®! ¾à, Ä¡·á ¸ðµÎ 12¿ùÀÌ.. 0 2,695 2020-12-08
775 ½î±»ÇÑÀÇ¿ø 12¿ùÀÇ ¼±¹° °°Àº À̺¥Æ® 0 1,218 2020-12-03
774 ¼º´©°¡º´¿ø Çѹæ°ú 12¿ù À̺¥Æ®! (¿¬¸»°¨»çÀ̺¥Æ®) 0 1,446 2020-12-03
773 ÀÚ¼ûÇÑÀÇ¿ø ¿¬¸» ÅëÅ« À̺¥Æ® 0 1,128 2020-12-01
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷